Cargando…
The next frontier of early lung cancer and minimal residual disease detection: is multiomics the solution?
Autores principales: | Rolfo, Christian, Russo, Alessandro, Malapelle, Umberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10195843/ https://www.ncbi.nlm.nih.gov/pubmed/37156171 http://dx.doi.org/10.1016/j.ebiom.2023.104605 |
Ejemplares similares
-
Targeted therapy and non-small cell lung cancer: a new era!
por: Malapelle, Umberto, et al.
Publicado: (2019) -
Pericardial Delivery of Biological Agents: The Next Frontier?
por: Govea, Alayn, et al.
Publicado: (2017) -
Next steps in the early detection of ovarian cancer
por: Bast, Robert C., et al.
Publicado: (2021) -
A strategy to overcome EGFR p.T790M cis p.L792F induced resistance to osimertinib
por: Malapelle, Umberto, et al.
Publicado: (2022) -
Diagnostic and prognostic biomarkers in oligometastatic non-small cell lung cancer: a literature review
por: Cortinovis, Diego, et al.
Publicado: (2021)